Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy

被引:204
作者
Lai, Ping-Shan
Lou, Pei-Jen
Peng, Cheng-Liang
Pai, Chin-Ling
Yen, Wei-Nen
Huang, Ming-Yi
Young, Tai-Horng
Shieh, Ming-Jium
机构
[1] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan
[3] Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan
[4] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 402, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 100, Taiwan
[6] Coll Med, Taipei 100, Taiwan
[7] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan
关键词
photochemical internalization; dendrimer; doxorubicin; cancer therapy;
D O I
10.1016/j.jconrel.2007.06.012
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Coupling anticancer drugs to synthetic polymers is a promising approach to improve the efficacy and reduce the side effects of these drugs. The pH-activated polymer has been demonstrated to be a successful drug delivery vehicle system, whereas the photochemical internalization (PCI) was invented for site-specific delivery of membrane impermeable macromolecules from endocytic vesicles into the cyrosol. In this study, doxorubicin (DOX) was conjugated to polyamidoamine (PAMAM) dendrimers via pH-sensitive and -insensitive linkers and was combined with different PCI strategies to evaluate the cytotoxic effects. Our results showed that both PCI strategies significantly improved the cytotoxicity, of free DOX on Ca9-22 cells at higher concentrations. The 'light after' PCI treatment was efficient in releasing DOX from the PAMAM-hyd-DOX conjugates, resulted in more nuclear accumulation of DOX and more cell death through synergistic effects. On the other hand, antagonism was observed when 'light before' PCI combined with PAMAM-hyd-DOX conjugate. The distribution of PAMAM-amide-DOX was mainly cytosolic with or without PCI treatments. Both PCI strategies failed to improve the cytotoxicity of PAMAM-amide-DOX conjugates. Our results provide invaluable information in the future design of drug-polymer complexes for multi-modality cancer treatments. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 42 条
[1]   Defective acidification in human breast tumor cells and implications for chemotherapy [J].
Altan, N ;
Chen, Y ;
Schindler, M ;
Simon, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1583-1598
[2]   PEGylated gene nanocarriers based on block catiomers bearing ethylenediamine repeating units directed to remarkable enhancement of photochemical transfection [J].
Arnida ;
Nishiyama, Nobuhiro ;
Kanayama, Naoki ;
Jang, Woo-Dong ;
Yamasaki, Yuichi ;
Kataoka, Kazunori .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) :208-215
[3]   Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change [J].
Bae, Y ;
Fukushima, S ;
Harada, A ;
Kataoka, K .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (38) :4640-4643
[4]  
Berg K, 1999, CANCER RES, V59, P1180
[5]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[6]   Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells [J].
David, A ;
Kopecková, P ;
Minko, T ;
Rubinstein, A ;
Kopecek, J .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (01) :148-157
[7]   Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells [J].
Demoy, M ;
Minko, T ;
Kopecková, P ;
Kopecek, J .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (01) :185-196
[8]   Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic [J].
Duncan, R ;
Gac-Breton, S ;
Keane, R ;
Musila, R ;
Sat, YN ;
Satchi, R ;
Searle, F .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :135-146
[9]   PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles [J].
Engesæter, BO ;
Bonsted, A ;
Berg, K ;
Hogset, A ;
Engebråten, O ;
Fodstad, O ;
Curiel, DT ;
Mælandsmo, GM .
CANCER GENE THERAPY, 2005, 12 (05) :439-448
[10]   Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications [J].
Esfand, R ;
Tomalia, DA .
DRUG DISCOVERY TODAY, 2001, 6 (08) :427-436